High Content Positional Biosensor Assay to Screen for Compounds that Prevent or Disrupt Androgen Receptor and Transcription Intermediary Factor 2 Protein-Protein Interactions-Reference-Cited by-同舟云学术

High Content Positional Biosensor Assay to Screen for Compounds that Prevent or Disrupt Androgen Receptor and Transcription Intermediary Factor 2 Protein-Protein Interactions

Published:2017-10-30 Issue: Volume: Page:211-227
ISSN:1064-3745
Container-title:Methods in Molecular Biology
language:
Short-container-title:

Author:

Hua Yun,Camarco Daniel P.,Strock Christopher J.,Johnston Paul A.

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4939-7357-6_13

Reference42 articles.

1. Colas P (2008) High-throughput screening assays to discover small-molecule inhibitors of protein interactions. Curr Drug Discov Technol 5:190–199

2. Dudgeon D, Shinde SN, Shun TY, Lazo JS, Strock CJ, Giuliano KA, Taylor DL, Johnston PA, Johnston PA (2010) Characterization and optimization of a novel protein-protein interaction biosensor HCS assay to identify disruptors of the interactions between p53 and hDM2. Assay Drug Dev Technol 8:437–458

3. Dudgeon D, Shinde SN, Hua Y, Shun TY, Lazo JS, Strock CJ, Giuliano KA, Taylor DL, Johnston PA, Johnston PA (2010) Implementation of a 220,000 compound HCS campaign to identify disruptors of the interaction between p53 and hDM2, and characterization of the confirmed hits. J Biomol Screen 15:152–174

4. Hua Y, Shun TY, Strock CJ, Johnston PA (2014) High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions. Assay Drug Dev Technol 12:395–418

5. Lalonde S, Ehrhardt DW, Loqué D, Chen J, Rhee SY, Frommer WB (2008) Molecular and cellular approaches for the detection of protein-protein interactions: latest techniques and current limitations. Plant J 53:610–635

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation–Drug leads for metastatic castration resistant prostate cancer;SLAS Discovery;2023-10

2. Emerging trends in developing biosensor techniques to undertake plant phosphoproteomic analysis;Journal of Proteomics;2022-02

3. Undesirable Status of Prostate Cancer Cells after Intensive Inhibition of AR Signaling: Post-AR Era of CRPC Treatment;Biomedicines;2021-04-12

4. Selecting a minimal set of androgen receptor assays for screening chemicals;Regulatory Toxicology and Pharmacology;2020-11

5. Assays to Interrogate the Ability of Compounds to Inhibit the AF-2 or AF-1 Transactivation Domains of the Androgen Receptor;ASSAY and Drug Development Technologies;2019-12-01